Is mRNA-1010 the breakthrough Moderna needs beyond COVID-19 vaccines?
Moderna’s mRNA-1010 has cleared a major regulatory hurdle, but evidence in older adults, higher reactogenicity and seasonal contracting could limit its early impact.
Pharma & Biotech